486
Views
6
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Risk assessments for chronic exposure of children and prospective parents to ethylbenzene (CAS No. 100-41-4)

, , , , , & show all
Pages 662-726 | Received 23 Sep 2014, Accepted 26 Apr 2015, Published online: 21 May 2015

References

  • Abrass CK. (2000). The nature of chronic progressive nephropathy in aging rats. Adv Ren Replace Ther, 7, 4–10.
  • Adgate JL, Church TR, Ryan AD, Ramachandran G, Fredrickson AL, Stock TH, et al. (2004). Outdoor, indoor, and personal exposure to VOCs in children. Environ Health Perspect, 112, 1386–92.
  • Agency for Toxic Substances and Disease Registry (ATSDR). (1999). Toxicological profile for ethylbenzene. U.S. Department of Health and Human Services.
  • American Chemistry Council Ethylbenzene Panel. (2001). Occupational exposures to ethylbenzene during styrene manufacturing.
  • American Chemistry Council Benzene, Toluene and Xylenes VCCEP Consortium. (2005). Xylenes Category: m-Xylene (CAS No. 108–38-3), o-Xylene (CAS No. 95–47-6), p-Xylene (CAS No. 106–42-3), Mixed Xylenes (CAS No. 1330–20-7). Voluntary Children's Chemical Evaluation Program (VCCEP) Tier, 1 Pilot Submission. October 6, 2005.
  • American Chemistry Council (ACC). (2006). Voluntary Children's Chemical Evaluation Program (VCCEP): Tier 1 Pilot Submission for Ethylbenzene (CAS No. 100–41-4). December 12, 2006. [Online] Available at: http://www.tera.org/peer/VCCEP/Ethylbenzene/EBWelcome.html. Accessed on 6 July 2014.
  • American Chemistry Council (ACC). (2007). Voluntary Children's Chemical Evaluation Program (VCCEP) Tier 1 Pilot Submission for Ethylbenzene (CAS No. 100–41-4). [Online] Available at: http://www.tera.org/Peer/VCCEP%20Ethylbenzene%20Revised%20-august%2010%202007.pdf. Accessed on 27 June 2014.
  • American Conference of Governmental Industrial Hygienists (ACGIH). (2011). Documentation of the Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) - Ethyl Benzene.
  • Anderson MJ, Miller SL, Milford JB. (2001). Source apportionment of exposure to toxic volatile organic compounds using positive matrix factorization. J Expo Anal Environ Epidemiol, 11, 295–307.
  • Andrew FD, Buschbom RL, Cannon WC, Miller RA, Montgomery LF, Phelps DW, Sikov, MR. (1981). Teratologic assessment of ethylbenzene and 2-ethoxyethanol. Submitted to NIOSH under Contract No, 210–79-0037. Richland, WA: Battelle Pacific Northwest Laboratory.
  • Angerer J, Wulf H. (1985). Occupational chronic exposure to organic solvents. XI. Alkylbenzene exposure of varnish workers: effects on hematopoetic system.Int Arch Occup Environ Health, 56, 307–21.
  • Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Wooten JV. (1994). Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin Chem, 40, 1401–04.
  • Ashmore MR, Dimitroulopoulou C. (2009). Personal exposure of children to air pollution. Atmos Environ, 43, 128–41.
  • Åstrand I, Engström J, Övrum P. (1978). Exposure to xylene and ethylbenzene. I. Uptake, distribution and elimination in man.Scand J Work Environ Health, 4, 185–94.
  • Bardoděj Z, Bardodějová E. (1970). Biotransformation of ethyl benzene, styrene and alpha-methylstyrene in man. Am Ind Hyg Assoc J, 31, 206–09.
  • Bardoděj Z, Círek A. (1988). Long-term study on workers occupationally exposed to ethylbenzene. J Hyg Epidemiol Microbiol Immunol, 32, 1–5.
  • Barnett JF Jr. (2006). Oral (Gavage) subchronic neurotoxicity study of ethylbenzene in rats with recovery group. Laboratory Project ID MH, V00001. Charles River DDS Argus Division Laboratory, Horsham, Pennsylvania. Sponsored by the Ethylbenzene Panel, American Chemistry Council, Arlington, VA.
  • Barton HA, Pastoor TP, Baetcke K, Chambers JE, Diliberto J, Doerrer NG, et al. (2006). The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments. Crit Rev Toxicol, 36, 9–35.
  • Batterman S, Hatzivasilis G, Jia C. (2006). Concentrations and emissions of gasoline and other vapors from residential vehicle garages. Atmos Environ, 40, 1828–44.
  • Batterman S, Jia C, Hatzivasilis G. (2007). Migration of volatile organic compounds from attached garages to residences: a major exposure source. Environ Res, 104, 224–40.
  • Batterman SA, Peng CY, Braun J. (2002). Levels and composition of volatile organic compounds on commuting routes in Detroit, Michigan. Atmos Environ, 36, 6015–30.
  • Baylis C. (1994). Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor.J Clin Invest, 94, 1823–29.
  • Blount BC, McElprang DO, Chambers DM, Waterhouse MG, Squibb KS, Lakind JS. (2010). Methodology for collecting, storing, and analyzing human milk for volatile organic compounds. J Environ Monit, 12, 1265–73.
  • Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, et al. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol, 36, 781–92.
  • Boobis AR, Daston GP, Preston RJ, Olin SS. (2009). Application of key events analysis to chemical carcinogens and noncarcinogens. Crit Rev Food Sci Nutr, 49, 690–707.
  • Bradley E, Gonzalez P, Layfield E, Read W, Speck D, Castle L. (2004). Investigation of Chemical Migration into Take-Away and Snack Foods. A03033. Central Science Laboratory, UK Food Standards Agency. http://www.ilsi.org/misc/isfp/session4/isfp53.pdf.
  • Braeuning A, Gavrilov A, Brown S, Wolf CR, Henderson CJ. (2014). Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. Toxicol Sci, 140, 259–70.
  • Bus JS. (2006). Proposed mode of action for ethylbenzene. Unpublished.
  • Capen CC. (2001). Toxic responses of the endocrine system. In: Klaassen CD, Ed. Casarett & Doull's Toxicology. The Basic Science of Poisons. 6th ed. New York: McGraw-Hill, pp. 463–98.
  • Cappaert NLM, Klis SFL, Muijser H, De Groot JCMJ, Kulig BM, Smoorenburg GF. (1999). The ototoxic effects of ethyl benzene in rats. Hear Res, 137, 91–102.
  • Cappaert NL, Klis SF, Baretta AB, Muijser H, Smoorenburg GF. (2000). Ethylbenzene-induced ototoxicity in rats: a dose-dependent mid-frequency hearing loss. J Assoc Res Otolaryngol, 1, 292–99.
  • Cappaert NLM, Klis SFL, Muijser H, Kulig BM, Smoorenburg GF. (2001). Simultaneous exposure to ethylbenzene and noise: synergistic effects on outer hair cells. Hear Res, 162, 67–79.
  • Cappaert NLM, Klis SFL, Muijser H, Kulig BM, Ravensberg LC Smoorenburg GF. (2002). Differential susceptibility of rats and guinea pigs to the ototoxic effects of ethyl benzene. Neurotoxicol Teratol, 24, 503–10.
  • Carlson GP. (2004). Comparison of the susceptibility of wild-type and CYP2E1 knockout mice to the hepatotoxic and pneumotoxic effects of styrene and styrene oxide. Toxicol Lett, 150, 335–39.
  • Carmichael NG, Barton HA, Boobis AR, Cooper RL, Dellarco VL, Doerrer NG, et al. (2006). Agricultural chemical safety assessment: a multi-sector approach to the modernization of human safety requirements. Crit Rev Toxicol, 36, 1–7.
  • Caron PJ, Bennet AP, Plantavid MM, Louvet J. (1994). Luteinizing hormone secretory pattern before and after removal of Leydig cell tumor of the testis. Eur J Endocrinol, 131, 156–59.
  • Carter JM, Lapham WW, Zogorski JS. (2008). Occurrence of volatile organic compounds in aquifers of the United States. JAWRA, 44, 399–416.
  • CDC/NIOSH. (2007). International Chemical Safety Card for Ethylbenzene. [Online] Available at: http://www.cdc.gov/niosh/ipcsneng/neng0268.html. Accessed on 27 June 2014.
  • Centers for Disease Control and Prevention (CDC). (2012). Consumption of cigarettes and combustible tobacco–United States, 2000–2011. MMWR, 61, 565–69.
  • Centers for Disease Control and Prevention (CDC). (2013). Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, September 2013. [Online] Available at: http://www.cdc.gov/exposurereport. Accessed on 27 June 2014.
  • Chan PC, Hasemani JK, Mahleri J, Aranyi C. (1998). Tumor induction in F344/N rats and B6C3F1 mice following inhalation exposure to ethylbenzene. Toxicol Lett, 99, 23–32.
  • Chang FK, Mao IF, Chen ML, Cheng SF. (2011). Urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to ethylbenzene. Ann Occup Hyg, 55, 519–25.
  • Charest-Tardif G, Tardif R, Krishnan K. (2006). Inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice. Toxicol. Appl Pharmacol, 210, 63–69.
  • Charles SM, Batterman SA, Jia C. (2007). Composition and emissions of VOCs in main- and side-stream smoke of research cigarettes. Atmos Environ, 41, 5371–84.
  • Charles SM, Jia C, Batterman SA, Godwin C. (2008). VOC and particulate emissions from commercial cigarettes: analysis of 2,5-DMF as an ETS tracer. Environ Sci Technol, 42, 1324–31.
  • Chen CS, Hseu YC, Liang SH, Kuo JY, Chen SC. (2008). Assessment of genotoxicity of methyl-tert-butyl ether, benzene, toluene, ethylbenzene, and xylene to human lymphocytes using comet assay. J Hazard Mater, 153, 351–6.
  • Chiesa L, Soncin S, Panseri S, Cantoni C. (2008). Release of ethylbenzene and styrene from plastic cheese containers. Vet Res Commun, 32, 319–21.
  • Chin BH, McKelvey JA, Tyler TR, Calisti LJ, Kozbelt SJ, Sullivan LJ. (1980). Absorption, distribution, and excretion of ethylbenzene, ethylcyclohexane and methylbenzene isomers in rats. Bull Environ Contam Toxicol, 24, 477–83.
  • Chin JY, Godwin C, Parker E, Robins T, Lewis T, Harbin P, Batterman S. (2014). Levels and sources of volatile organic compounds in homes of children with asthma. Indoor Air, 24, 403–15.
  • Clayton RN, Huhtaniemi IT. (1982). Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature, 299, 56–59.
  • Clegg ED, Cook JC, Chapin RE, Foster PMD, Daston GP. (1997). Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. Reprod Toxicol, 11, 107–21.
  • Cometto-Muñiz JE, Abraham MH. (2015). Compilation and analysis of types and concentrations of airborne chemicals measured in various indoor and outdoor human environments. Chemosphere, 127, 70–86.
  • Conolly RB, Beck BD, Goodman JI. (1999). Stimulating research to improve the scientific basis of risk assessment. Toxicol Sci, 49, 1–4.
  • Cook JC, Klinefelter GR, Hardisty JF, Sharpe RM, Foster PMD. (1999). Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans. Crit Rev Toxicol, 29, 169–261.
  • Cooke BA, Sullivan MHF. (1985). The mechanisms of LHRH agonist action in gonadal tissues. Mol Cell Endocrinol, 41, 115–22.
  • Cossec B, Cosnier F, Burgart M, Nunge H, Grossmann S. (2010). Glutathione pathway in ethylbenzene metabolismml: novel biomarkers of exposure in the rat. Chemosphere, 81, 1334–41.
  • Cragg ST, Clarke EA, Daly IW, Miller RR, Terrill JB, Ouellette RE. (1989). Subchronic inhalation toxicity of ethylbenzene in mice, rats and rabbits. Fundam Appl Toxicol, 13, 399–408.
  • Cruzan G, Carlson GP, Johnson KA, Andrews LS, Banton MI, Bevan C, Cushman JR. (2002). Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites. Regul Toxicol Pharmacol, 35, 308–19.
  • Cruzan G, Bus J, Banton M, Gingell R, Carlson G. (2009). Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolismml: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Regul Toxicol Pharmacol, 55, 205–18.
  • Cruzan G, Bus J, Hotchkiss J, Harkema J, Banton M, Sarang S. (2012). CYP2F2-generated metabolites, not styrene oxide, are a key event mediating the mode of action of styrene-induced mouse lung tumors. Regul Toxicol Pharmacol, 62, 214–20.
  • Cunningham ML, Maronpot RR, Thompson M, Bucher JR. (1994). Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam. Toxicol Appl Pharmacol, 124, 31–38.
  • Dalton SR, Miller RT, Meyer SA. (2003). The herbicide metolachlor induces liver cytochrome P450s 2B1/2 and 3A1/2, but not thyroxine-uridine dinucleotide phosphate glucuronosyltransferase and associated thyroid gland activity. Int J Toxicol, 22, 287–95.
  • Dateki M, Kunitomo M, Yoshioka K, Yanai K, Nakasono S, Negishi T. (2011). Adaptive gene regulation of pyruvate dehydrogenase kinase isozyme 4 in hepatotoxic chemical-induced liver injury and its stimulatory potential for DNA repair and cell proliferation. J Recept Signal Transduct Res, 31, 85–95.
  • Dawson HE, McAlary T. (2009). A compilation of statistics for VOCs from post-1990 indoor air concentration studies in North American residences unaffected by subsurface vapor intrusion. Ground Water Monit Remediat, 29, 60–9.
  • Dean BJ, Brooks TM, Hodson-Walker G, Hutson DH. (1985). Genetic toxicology testing of 41 industrial chemicals. Mutat Res, 153, 57–77.
  • De Celis R, Feria-Velasco A, González-Unzaga M, Torres-Calleja J, Pedrón-Nuevo N. (2000). Semen quality of workers occupationally exposed to hydrocarbons. Fertil Steril, 73, 221–28.
  • De Groot LJ, Besser M, Burger HG, Jameson JL, Loriaux DL, Marshall JC, et al. (1995). Endocrinology. 3rd ed. Philadelphia, PA: WB Saunders.
  • Delgado-Saborit JM, Aquilina NJ, Meddings C, Baker S, Harrison RM. (2009). Model development and validation of personal exposure to volatile organic compound concentrations. Environ Health Perspect, 117, 1571–79.
  • Delgado-Saborit JM, Aquilina NJ, Meddings C, Baker S, Harrison RM. (2011). Relationship of personal exposure to volatile organic compounds to home, work and fixed site outdoor concentrations. Sci Total Environ, 409, 478–88.
  • Dodson RE, Houseman EA, Levy JI, Spengler JD, Shine JP, Bennett DH. (2007). Measured and modeled personal exposures to and risks from volatile organic compounds. Environ Sci Technol, 41, 8498–505.
  • Dodson RE, Levy JI, Spengeler JD, Shine JP, Bennett DH. (2008). Influence of basements, garages, and common hallways on indoor residential volatile organic compound concentrations. Atmos Environ, 42, 1569–81.
  • Doe JE, Boobis AR, Blacker A, Dellarco VL, Doerrer NG, Franklin C, et al. (2006). A tiered approach to systemic toxicity testing for agricultural chemical safety assessment. Crit Rev Toxicol, 36, 37–68.
  • D’Souza JC, Jia C, Mukherjee B, Batterman S. (2009). Ethnicity, housing and personal factors as determinants of VOC exposures. Atmos Environ, 43, 2884–92.
  • Dutkiewicz T, Tyras H. (1967). A study of the skin absorption of ethylbenzene in man. Br J Ind Med, 24, 330–32.
  • Edwards RD, Jurvelin J, Koistinen K, Saarela K, Jantunen M. (2001a). VOC source identification from personal and residential indoor, outdoor and workplace microenvironment samples in EXPOLIS-Helsinki, Finland. Atmos Environ, 35, 4829–41.
  • Edwards RD, Jurvelin J, Saarela K, Jantunen M. (2001b). VOC concentrations measured in personal samples and residential indoor, outdoor and workplace microenvironments in EXPOLIS-Helsinki, Finland. Atmos Environ, 35, 4531–43.
  • Edwards RD, Schweizer C, Jantunen M, Lai HK, Bayer-Oglesby L, Katsouyanni K, et al. (2005). Personal exposures to VOC in the upper end of the distribution—relationships to indoor, outdoor and workplace concentrations. Atmos Environ, 39, 2299–307.
  • Edwards RD, Schweizer C, Llacqua V, Lai HK, Jantunen M, Bayer-Oglesby L, Künzli N. (2006). Time–activity relationships to VOC personal exposure factors. Atmos Environ, 40, 5685–700.
  • Ehret-Henry J, Ducruet V, Luciani A, Feigenbaum A. (1994). Styrene and ethylbenzene migration from polystyrene into dairy products by dynamic purge-and-trap gas chromatography. J Food Sci, 59, 990–92.
  • El Mastri AM, Smith JN, Williams RT. (1956). The metabolism of alkylbenzenes: n-Propylbenzene and n-butylbenzene with further observations on ethylbenzene. Biochem J, 64, 50–56.
  • Elcombe CR, Peffer RC, Wolf DC, Bailey J, Bars R, Bell D. (2014). Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol, 44, 64–82.
  • Engström J, Bjurström R. (1978). Exposure to xylene and ethylbenzene. II. Concentration in subcutaneous adipose tissue.Scand J Work Environ Health, 4, 195–203.
  • Engström KM. (1984). Metabolism of inhaled ethylbenzene in rats. Scand J Work Environ Health, 10, 83–87.
  • Environment Canada/Health Canada. (2014). Draft Screening Assessment Report Ethylbenzene Chemical Abstracts Service Registry Number 100–41-4.
  • Faber WD, Roberts LSG, Stump DG, Tardif R, Krishnan K, Tort M, et al. (2006). Two generation reproduction study of ethylbenzene by inhalation in Crl-CD rats. Birth Defects Res B Dev Reprod Toxicol, 77, 10–21.
  • Faber WD, Roberts LSG, Stump DG, Beck M, Kirkpatrick D, Regan KS, et al. (2007). Inhalation developmental neurotoxicity study of ethylbenzene in Crl-CD rats. Birth Defects Res B Dev Reprod Toxicol, 80, 34–48.
  • Fisher J, Mahle D, Bankston L, Greene R, Gearhart J. (1997). Lactational transfer of volatile chemicals in breast milk. Am Ind Hyg Assoc J, 58, 425–31.
  • Fleming-Jones ME, Smith RE. (2003). Volatile organic compounds in foods: a five year study. J Agric Food Chem, 51, 8120–27.
  • Florin I, Rutberg L, Curvall M, Enzell CR. (1980). Screening of tobacco smoke constituents for mutagenicity using the Ames’ test. Toxicology, 15, 219–32.
  • Foran JA, ed. (1997). Principles for the Selection of Doses in Chronic Rodent Bioassays. Washington, DC: ILSI Risk Science Institute, ILSI Press, pp. 119–21.
  • Frocht A, Fillit H. (1984). Renal disease in the geriatric patient. J Am Geriatr Soc, 32, 28–43.
  • Freundt KJ, Römer KG, Federsel RJ. (1989). Decrease of inhaled toluene, ethyl benzene, m-xylene, or mesitylene in rat blood after combined exposure to ethyl acetate. Bull Environ Contam Toxicol, 42, 495–98.
  • Fuciarelli AF. (2000). Ethylbenzene two-week repeated-dose inhalation toxicokinetic study report. Battelle, Richland, Washington. Battelle Project, #G002840-LQ. Conducted for the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
  • Fuente A, McPherson B, Cardemil F. (2013). Xylene-induced auditory dysfunction in humans. Ear Hear, 34, 651–60.
  • Fujita EM, Campbell DE, Zielinska B, Arnott WP, Chow JC. (2011). Concentrations of Air Toxics in Motor Vehicle-Dominated Environments. Research Report #156. Health Effects Institute, Boston, MA. [Online] Available at: http://pubs.healtheffects.org/view.php?id-354. Accessed on 27 June 2014.
  • Gagnaire F, Langlais C. (2005). Relative otoxicity of 21 aromatic solvents. Arch Toxicol, 79, 346–54.
  • Gagnaire F, Langlais C, Grossmann S, Wild P. (2007). Ototoxicity in rats exposed to ethylbenzene and to two technical xylene vapours for 13 weeks. Arch Toxicol, 81, 127–43.
  • Gant TW, Rao DN, Mason RP, Cohen GM. (1988). Redox cycling and sulphydryl arylation; Their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem Biol Interact, 65, 157–73.
  • Geter DR, Bhat VS, Gollapudi BB, Sura R, Hester SD. (2014). Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway. Toxicol Sci, 138, 425–45.
  • Gibson DP, Brauninger R, Shaffi HS, Kerckaert GA, LeBoeuf RA, Isfort RJ, Aardema MJ. (1997). Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals. Mutat Res, 392, 61–70.
  • Gordon SM, Callahan PJ, Nishioka MG, Brinkman MC, O’Rourke MK, Lebowitz MD, Moschandreas DJ. (1999). Residential environmental measurements in the National Human Exposure Assessment Survey (NHEXAS) pilot study in Arizona: preliminary results for pesticides and VOCs. J Exp Anal Environ Epidemiol, 9, 456–70.
  • Gram TE. (1997). Chemically reactive intermediates and pulmonary xenobiotic toxicity. Pharmacol Rev, 49, 297–342.
  • Gramshaw JW, Vandenburg HJ. (1995). Compositional analysis of samples of thermoset polyester and migration of ethylbenzene and styrene from thermoset polyester into pork during cooking. Food Addit Contam, 12, 223–34.
  • Grant WM, Thomas CC. (1986). Toxicology of the Eye. 3rd ed. Springfield, IL: Informa Healthcare.
  • Grasso P, Hinton RH. (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutat Res, 248, 271–90.
  • Green T. (2000). Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action. Environ Health Perspect, 108, 261–64.
  • Green T, Lee R, Toghill A, Meadowcroft S, Lund V, Foster J. (2001). The toxicity of styrene to the nasal epithelium of mice and rats: studies on the mode of action and relevance to humans. Chem Biol Interact, 137, 185–202.
  • Greenlee WF, Sun JD, Bus JS. (1981). A proposed mechanism of benzene toxicity: formation of reactive intermediates from polyphenol metabolites. Toxicol Appl Pharmacol, 59, 187–95.
  • Griffin RJ, Dudley CN, Cunningham ML. (1996). Biochemical effects of the mouse hepatocarcinogen oxazepamml: similarities to phenobarbital. Toxicol Sci, 29, 147–54.
  • Gromiec JP, Piotrowski JK. (1984). Urinary mandelic acid as an exposure test for ethylbenzene. Int Arch Occup Environ Health, 55, 61–72.
  • Guthrie OW, Xu H, Wong BA, McInturf SM, Reboulet JE, Ortiz PA, Mattie DR. (2014). Exposure to low levels of jet-propulsion fuel impairs brainstem encoding of stimulus intensity. J Toxicol Environ Health A, 77, 261–80.
  • Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell, 100, 57–70.
  • Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell, 144, 646–74.
  • Hard GC. (2002). Significance of the renal effects of ethylbenzene for assessing human carcinogenic risk. Toxicol Sci, 69, 30–41.
  • Hard GC, Khan KN. (2004). A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol Pathol, 32, 171–80.
  • Hard GC, Johnson KJ, Cohen SM. (2009). A comparison of rat chronic progressive nephropathy with human renal disease-implications for human risk assessment. Crit Rev Toxicol, 39, 332–46.
  • Hard GC, Banton MI, Bretzlaff RS, Dekant W, Fowles JR, Mallett AK, et al. (2013). Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity. Toxicol Sci, 132, 268–75.
  • Hardin BD, Bond GP, Sikov MR, Andrew FD, Beliles RP, Niemeier RW. (1981). Testing of selected workplace chemicals for teratogenic potential. Scand J Work Environ Health, 7, 66–75.
  • Harrison RM, Delgado-Saborit JM, Baker SJ, Aquilina N, Meddings C, Harrad S, et al. (2009). Measurement and Modeling of Exposure to Selected Air Toxics for Health Effects Studies and Verification by Biomarkers. Research Report 143. Health Effects Institute, Boston, MA. [Online] Available at: http://pubs.healtheffects.org/view.php?id = 329. Accessed on 27 June 2014.
  • Harvilchuck JA, Carlson GP. (2006). Comparison of styrene and its metabolites styrene oxide and 4-vinylphenol on cytotoxicity and glutathione depletion in Clara cells of mice and rats. Toxicology, 227, 165–72.
  • Haseman JK, Arnold J. (1990). Tumor incidences in Fisher 344 rats: NTP historical data. In: Boorman GA, Eustis SL, Montgomery C, Elwell MR, MacKenzie WF, Eds. Pathology of the Fisher Rat: Reference and Atlas. San Diego: Academic Press, pp. 555–64.
  • Health Canada. (2010a). Regina Indoor Air Quality Study (2007): Data Summary for Volatile Organic Compound Sampling (http://publications.gc.ca/collections/collection_2012/sc-hc/H128–1-10–617-eng.pdf).
  • Health Canada. (2010b). Windsor Exposure Assessment Study (2005–2006): Data Summary for Volatile Organic Compound Sampling (http://publications.gc.ca/collections/collection_2012/sc-hc/H128–1-10–618-eng.pdf).
  • Health Canada. (2013). Edmonton Indoor Air Quality Study (2010): Volatile Organic Compounds (VOC) Data Summary (http://publications.gc.ca/collections/collection_2014/sc-hc/H144–15-2013-eng.pdf).
  • Heavner DL, Morgan WT, Ogden MW. (1995). Determination of volatile organic compounds and ETS apportionment in 49 homes. Environ Int, 21, 3–21.
  • Heavner DL, Morgan WT, Ogden MW. (1996). Determination of volatile organic compounds and respirable suspended particulate matter in New Jersey and Pennsylvania homes and workplaces. Environ Int, 22, 159–83.
  • Helmes CT. (1990). Written communication (August 14) to Yee-Wan Stevens, Agency for Toxic Substances and Disease Registry, regarding workplace exposure levels of ethylbenzene. Washington, DC: Synthetic Organic Chemical Manufacturers Association (as cited in ATSDR, [1999]). Unable to find to verify format
  • Henderson L, Brusick D, Ratpan F, Veenstra G. (2007). A review of the genotoxicity of ethylbenzene. Mutat Res, 635, 81–9.
  • Héroux MÈ, Gauvin D, Gilbert NL, Guay M, Dupuis G, Legris M, Lévesque B. (2008). Housing characteristics and indoor concentrations of selected volatile organic compounds (VOCs) in Quebec City, Canada. Indoor and Built Environment, 17, 128–37.
  • Héroux ME, Clark N, Van Ryswyk K, Mallick R, Gilbert NL, Harrison I, et al. (2010). Predictors of indoor air concentrations in smoking and non-smoking residences. Int J Environ Res Public Health, 7, 3080–99.
  • Hinwood AL, Rodriguez C, Runnion T, Farrar D, Murray F, Horton A, et al. (2007). Risk factors for increased BTEX exposure in four Australian cities. Chemosphere, 66, 533–41.
  • Hodgson AT, Levin H. (2003). Volatile Organic Compounds in Indoor Air: A Review of Concentrations Measured in North America since 1990. Report LBNL-51715. Lawrence Berkeley National Laboratory, Berkeley, CA. [Online] Available at: http://energy.lbl.gov/IED/pdf/LBNL-51715.pdf. Accessed on 27 June 2014.
  • Hodgson AT, Daisey JM, Mahanama KRR, Ten Brinke J. (1996). Use of volatile tracers to determine the contribution of environmental tobacco smoke to concentrations of volatile organic compounds in smoking environments. Environ Int, 22, 295–307.
  • Holsapple MP, Pitot HC, Cohen SH, Boobis AR, Klaunig JE, Pastoor T, et al. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci, 89, 51–56.
  • Holz O, Scherer G, Brodtmeier S, Koops F, Warncke K, Krause T, et al. (1995). Determination of low level exposure to volatile aromatic hydrocarbons and genotoxic effects in workers at a styrene plant. Occup Environ Med, 52, 420–8.
  • Huhtaniemi IT. (1983). Gonadotrophin receptors: correlates with normal and pathological functions of the human ovary and testis. In Clayton HM, Back W, Eds. Clinical Endocrinology and Metabolismml: Receptors in Health and Disease. Philadelphia: W.B. Saunders, pp. 117–32.
  • Hun DE, Corsi RL, Morandi MT, Siegel JA. (2011). Automobile proximity and indoor residential concentrations of BTEX and MTBE. Build Environ, 46, 45–53.
  • Ilgen E, Karfich N, Levsen K, Angerer J, Schneider P, Heinrich J, et al. (2001). Aromatic hydrocarbons in the atmospheric environment part I: indoor versus outdoor sources, the influence of traffic. Atmos Environ, 35, 1235–52.
  • Imaoka S, Funae Y. (1991). Induction of cytochrome P450 isozymes in rat liver by methyl n-alkyl ketones and n-alkylbenzenes: effects of hydrophobicity of inducers on inducibility of cytochrome P450. Biochem Pharmacol, 42, S143–50.
  • International Agency for Research on Cancer (IARC). (2000). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 77. Ethylbenzene [Online] Available at: http://monographs.iarc.fr/ENG/Monographs/vol77/mono77–10.pdf. Accessed on 8 July 2014.
  • International Commission on Radiological Protection (ICRP). (1975). Annals of the ICRP. Report on the Task Group on Reference Man. ICRP Publication, 23. Oxford: Pergamon Press.
  • International Programme on Chemical Safety (IPCS). (1996). Ethylbenzene. http://www.inchem.org/documents/ehc/ehc/ehc186.htm. Accessed on September 26, 2006.
  • Irons RD, Greenlee WF, Wierda D, Bus JS. (1981). Relationship between benzene metabolism and toxicity: a proposed mechanism for the formation of reactive intermediates from polyphenol metabolites. Adv Exp Med Biol, 136, 229–43.
  • International Styrene Industry Forum (ISIF). Website Homepage. (2012). [Online] Available at: http://www.styreneforum.org/index.html. Accessed on 27 June 2014.
  • Jia, C. (2007). Volatile Organic Compounds in Industrial, Urban, and Suburban Areas: Sources and Exposures. (Doctor of Philosophy), University of Michigan, Ann Arbor, MI. (3276194)
  • Jia C, Batterman S, Godwin C. (2008a). VOCs in industrial, urban and suburban neighborhoods, Part 1: indoor and outdoor concentrations, variation, and risk drivers. Atmos Environ, 42, 2083–100.
  • Jia C, Batterman S, Godwin C. (2008b). VOCs in industrial, urban and suburban neighborhoods, Part 2: factors affecting indoor and outdoor concentrations. Atmos Environ, 42, 2101–16.
  • Jia C, D’Souza J, Batterman S. (2008c). Distributions of personal VOC exposures: a population-based analysis. Environ Int, 34, 922–31.
  • Jia C, Yu X, Masiak W. (2012). Blood/air distribution of volatile organic compounds (VOCs) in a nationally representative sample. Sci Total Environ, 419, 225–32.
  • Johnson AC, Nylén PR. (1995). Effects of industrial solvents on hearing. Occup Med, 10, 623–40.
  • Johnson M, Hudgens E, Williams R, Andrews G, Neas L, Gallagher J, Özkaynak H. (2009). A participant-based approach to indoor/outdoor air monitoring in community health studies. J Expo Sci Environ Epidemiol, 19, 492–501.
  • Johnson MM, Williams R, Fan Z, Lin L, Hudgens E, Gallagher J, et al. (2010). Participant-based monitoring of indoor and outdoor nitrogen dioxide, volatile organic compounds, and polycyclic aromatic hydrocarbons among MICA-Air households. Atmos Environ, 44, 4927–36.
  • Juberg DR, Mudra DR, Hazelton GA, Parkinson A. (2006). The effect of fenbuconazole on cell proliferation and enzyme induction in the liver of female CD1 mice. Toxicol Appl Pharmacol, 214, 178–87.
  • Kaplan C, Pasternack B, Shah H, Gallo G. (1975). Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol, 80, 227–34.
  • Kaubisch N, Daly JW, Jerina DM. (1972). Arene oxides as intermediates in the oxidative metabolism of aromatic compounds. Isomerization of methyl-substituted arene oxides. Biochemistry, 11, 3080–88.
  • Kawai T, Yasugi T, Mizunuma K, Horiguchi S, Iguchi H, Uchida Y, et al. (1992). Comparative evaluation of urinalysis and blood analysis as means of detecting exposure to organic solvents at low concentrations. Int Arch Occup Environ Health, 64, 223–34.
  • Kerckaert GA, Brauninger R, LeBoef RA, Isfort RJ. (1996). Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays. Env Health Perspect, 104, 1075–84.
  • Kim JH, Moon JY, Park EY, Lee KH, Hong YC. (2011). Changes in oxidative stress biomarker and gene expression levels in workers exposed to volatile organic compounds. Ind Health, 49, 8–14.
  • Kim SR, Halden RU, Buckley TJ. (2007). Volatile organic compounds in human milk: methods and measurements. Environ Sci Technol, 41, 1662–67.
  • Kim YM, Harrad S, Harrison RM. (2001). Concentrations and sources of VOCs in urban domestic and public microenvironments. Environ Sci Technol, 35, 997–1004.
  • Kim YM, Harrad S, Harrison RM. (2002). Levels and sources of personal inhalation exposure to volatile organic compounds. Environ Sci Technol, 36, 5405–10.
  • Kinney PL, Chillrud SN, Ramstrom S, Ross J, Spengler JD. (2002). Exposures to multiple air toxics in New York City. Environ Health Perspect, 110, 539–46.
  • Kinney PL, Chillrud SN, Sax S, Ross JM, Macintosh D, Myatt TA, Spengler JD. (2008). Toxic Exposure Assessment: a Columbia-Harvard (TEACH) Study (The Los Angeles Report). Mickey Leland National Urban Air Toxics Research Center Research Report Number 9. [Online] Available at: https://sph.uth.edu/mleland/attachments/2008%20LA%20TEACH%206_19_08b.pdf. Accessed on 27 June 2014.
  • Kinney PL, Chillrud SN, Sax S, Ross JM, Pederson DC, Johnson D, et al. (2005). Toxic Exposure Assessment: a Columbia-Harvard (TEACH) Study (The New York City Report). Mickey Leland National Urban Air Toxics Research Center Research Report Number 3. [Online] Available at: https://sph.uth.edu/mleland/attachments/NY_TEACH%20Study3.pdf. Accessed on 27 June 2014.
  • Kirman CR, Sweeney LM, Meek ME, Gargas ML. (2003). Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol, 38, 345–67.
  • Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, et al. (2003). PPARα agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol, 33, 655–780.
  • Klepeis NE, Nelson WC, Ott WR, Robinson JP, Tsang AM, Switzer P, et al. (2001). The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol, 11, 231–52.
  • Kligman AM. Report to RIFM. Cited in Opdyke DLJ. (1975). Ethylbenzene. Food Cosmet Toxicol, 13, 803–4.
  • Knecht U, Reske A, Woitowitz HJ. (2000). Biological monitoring of standardized exposure to ethylbenzene: evaluation of a biological tolerance (BAT) value. Arch Toxicol, 73, 632–40.
  • Kotzias D, Geiss O, Tirendi S, Barrero-Moreno J, Reina V, Gotti A, et al. (2009). Exposure to multiple air contaminants in public buildings, schools and kindergartens-the European Indoor Air Monitoring and Exposure Assessment (AIRMEX) study. Fresenius Environ Bull, 18, 670–81.
  • Kotzias D, Koistinen K, Kephalopoulos S, Schlitt C, Carrer P, Maroni M, et al. (2005). The INDEX project. Critical Appraisal of the Setting and Implementation of Indoor Exposure Limits in the EU. Final Report. European Commission Joint Research Center.
  • Kwon J, Weisel CP, Turpin BJ, Zhang J, Korn LR, Morandi MT, et al. (2006). Source proximity and outdoor-residential VOC concentrations: results from the RIOPA study. Environ Sci Technol, 40, 4074–82.
  • Ladefoged O, Lam HR, Ostergaard G, Hansen EV, Hass U, Lund SP, Simonsen L. (1998). Toxicity of the styrene metabolite, phenylglyoxylic acid, in rats after three months’ oral dosing. Neurotoxicology, 19, 721–37.
  • Leonhartsberger N, Ramoner R, Aigner F, Stoehr B, Pichler R. (2011). Increased incidence of Leydig cell tumours of the testis in the era of improved imaging techniques. BJU Int, 108, 1603–7.
  • Li AA, Maurissen JPJ, Barnett JF Jr, Foss J, Freshwater L, Garman RH, et al. (2010). Oral gavage subchronic neurotoxicity and inhalation subchronic immunotoxicity studies of ethylbenzene in the rat. Neurotoxicology, 31, 247–58.
  • Lickly TD, Breder CV, Rainey ML. (1995). A model for estimating the daily dietary intake of a substance from food-contact articles: styrene from polystyrene food-contact polymers. Regul Toxicol Pharmacol, 21, 406–17.
  • Lim SK, Shin HS, Yoon KS, Kwack SJ, Um YM, Hyeon JH, et al. (2014). Risk assessment of volatile organic compounds benzene, toluene, ethylbenzene, and xylene (BTEX) in consumer products. J Toxicol Environ Health A, 77, 1502–21
  • Lioy PJ, Fan Z, Zhang J, Georgopoulos P, Wang S, Ohman-Strickland P, et al. (2011). Personal and ambient exposures to air toxics in Camden, New Jersey. Research Report #160. Health Effects Institute, Boston, MA. [Online] Available at: http://pubs.healtheffects.org/view.php?id = 364. Accessed on 27 June 2014.
  • Lock EA, Hard GC. (2004). Chemically induced renal tubule tumors in the laboratory rat and mouse: review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit Rev Toxicol, 34, 211–99.
  • Logue JM, McKone TE, Sherman MH, Singer BC. (2011). Hazard assessment of chemical air contaminants measured in residences. Indoor Air, 21, 92–109.
  • López P, Batlle R, Salafranca J, Nerin C. (2008). Efficiency of whole and skimmed powdered milk for trapping volatile compounds released from plastic containers in high-temperature applications. J Food Prot, 71, 1889–97.
  • Lu BQ, Zhen ZH. (1989). Health standards for ethylbenzene in the air of workplaces. (In Chinese) Beijing: Chinese Academy of Preventive Medicine Institute of Occupational Medicine. Cited in: International Programme on Chemical Safety (IPCS). (1996). Environmental Health Criteria 186. Ethylbenzene. [Online] Available at: http://www.inchem.org/documents/ehc/ehc/ehc186.htm. Accessed on 8 July 2014.
  • Maltoni C, Conti B, Cotti G, Belpoggi F. (1985). Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: current results and ongoing research. Am J Ind Med, 7, 415–46.
  • Maltoni C, Ciliberti A, Pinto C, Soffritti M, Bellpoggi F, Menarini L. (1997). Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels, and major gasoline aromatics in rats. Ann NY Acad Sci, 837, 15–52.
  • McCarthy MC, Hafner HR, Chinkin LR, Charrier JG. (2007). Temporal variability of selected air toxics in the United States. Atmos Environ, 41, 7180–94.
  • McGregor DB, Brown A, Cattanach P, Edwards I, McBride D, Riach C, Caspary WJ. (1988). Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay: III. 72 coded chemicals. Environ Mol Mutagen, 12, 85–154.
  • McLanahan ED, El-Masri HA, Sweeney LM, Kopylev LY, Clewell HJ, Wambaugh JF, Schlosser PM. 2012. Physiologically based pharmacokinetic model use in risk assessment–Why being published is not enough. Toxicol Sci, 126, 5–15.
  • McMahon RE, Sullivan HR. (1966). Microsomal hydroxylation of ethylbenzene. Stereospecificity and the effect of phenobarbital induction.Life Sci, 5, 921–26.
  • McMahon RE, Sullivan HR. (1968). Nature of in vivo conversion of L(-) methylphenyl carbinol to D(-) mandelic acid in rat. Pharmacologist, 10, 203–08.
  • Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, et al. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol, 33, 591–653.
  • Meek ME, Palermo CM, Bachman AN, North CM, Lewis RJ. (2014). Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol, 34, 595–606.
  • Mellert W, Deckardt K, Kaufmann W, van Ravenzwaay B. (2004). Subchronic toxicity study in Wistar rats. Oral Administration by gavage for 3 months. Experimental Toxicology and Ecology, BASF, Ludwigshafen, Germany. Laboratory Project Identification Project No. 50C0153/99153. Sponsored by the Styrenics Steering Committee, CEFIC, Brussels, Belgium.
  • Mellert W, Deckardt K, Kaufmann W, van Ravenzwaay B. (2007). Ethylbenzene: 4- and 13-week rat oral toxicity. Arch Toxicol, 81, 361–70.
  • Melnick RL, Burns KM, Ward JM, Huff J. (2012). Chemically exacerbated chronic progressive nephropathy not associated with renal tubular tumor induction in rats: an evaluation based on 60 carcinogenicity studies by the National Toxicology Program. Toxicol Sci, 128, 346–56.
  • Melski K, Zabielski J, Kubera H. (2003). Model Study on Intensified Migration of Volatile Substances from Food Contacting Plastic Materials During Repeated Microwaving. Electronic Journal of Polish Agricultural Universities, Food Science and Technology. 6. [Online] Available at: http://www.ejpau.media.pl. Accessed on 7 Jul 2014.
  • Midorikawa K, Uchida T, Okamoto Y, Toda C, Sakai Y, Ueda K, et al. (2004). Metabolic activation of carcinogenic ethylbenzene leads to oxidative DNA damage. Chem Biol Interact, 150, 271–81.
  • Miller L, Lemke LD, Xu X, Molaroni SM, You H, Wheeler AJ, et al. (2010). Intra-urban correlation and spatial variability of air toxics across an international airshed in Detroit, Michigan (USA) and Windsor, Ontario (Canada). Atmos Environ, 44, 1162–74.
  • Miller L, Xu X, Grgicak-Mannion A, Brook J, Wheeler A. (2012). Multi-season, multi-year concentrations and correlations amongst the BTEX group of VOCs in an urbanized industrial city. Atmos Environ, 61, 305–15.
  • Mohamed MF, Kang D, Aneja VP. (2002). Volatile organic compounds in some urban locations in the United States. Chemosphere, 47, 863–82.
  • Mohtashamipur E, Norpoth K, Woelke U, Huber P. (1985). Effects of ethylbenzene, toluene, and xylene on the induction of micronuclei in bone marrow polychromatic erythrocytes of mice. Arch Toxicol, 58, 106–9.
  • Molnár J, Paksy KA, Náray M. (1986). Changes in the rat's motor behaviour during 4-hr inhalation exposure to prenarcotic concentrations of benzene and its derivatives. Acta Physiol Hung, 67, 349–54.
  • Morgan DL, Cooper SW, Carlock DL, Sykora JJ, Sutton B, Mattie DR, McDougal JN. (1991). Dermal absorption of neat and aqueous volatile organic chemicals in the Fischer 344 rat. Environ Res, 55, 51–63.
  • Mutti A, Falzoi M, Romanelli A, Bocchi MC, Ferroni C, Franchini I. (1988). Brain dopamine as a target for solvent toxicity: effects of some monocyclic aromatic hydrocarbons. Toxicology, 49, 77–82.
  • Muttray A, Wolff U, Jung D, Konietzko J. (1997). Blue-yellow deficiency in workers exposed to low concentrations of organic solvents. Int Arch Occup Environ Health, 70, 407–12.
  • National Research Council (NRC). (2014). Review of EPA's Integrated Risk Information System (IRIS) Process. Washington, DC: National Academies Press.
  • National Toxicology Program (NTP). (1986). Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71–43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser, 289, 1–277.
  • National Toxicology Program (NTP). (1990). Toxicology and Carcinogenesis Studies of α-Methylbenzyl Alcohol (CAS No. 98–85-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser, 369, 1–171.
  • National Toxicology Program (NTP). (1992a). Toxicity studies of ethylbenzene (CAS No. 100–41-4) in F344/N rats and B6C3F1 mice (inhalation studies). NTP Tox. 10. NIH Publication No., 92–3129. PB93–149722. National Toxicology Program, U.S. Dept. of Health and Human Services. North Carolina: Research Triangle Park.
  • National Toxicology Program (NTP). (1992b). Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91–20-3) in B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser, 410, 1–172.
  • National Toxicology Program (NTP). (1999). Toxicology and Carcinogenesis Studies of Ethylbenzene (CAS No. 100–41-4) in F344 Rats and B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser, 466, 1–231.
  • National Toxicology Program (NTP). (2009). Toxicology and Carcinogenesis Studies of Cumene (CAS No. 98–82-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser, 542, 1–206.
  • Needham LL, Wang RY. (2002). Analytic considerations for measuring environmental chemicals in breast milk. Environ Health Perspect, 110, A317–24.
  • Nerín C, Acosta D. (2002). Behavior of some solid food simulants in contact with several plastics used in microwave ovens. J Agric Food Chem, 50, 7488–92.
  • Nerín C, Acosta D, Rubio C. (2002). Potential migration release of volatile compounds from plastic containers destined for food use in microwave ovens. Food Addit Contam, 19, 594–601.
  • Nestmann ER, Lee EGH, Matula TI, Douglas GR, Mueller JC. (1980). Mutagenicity of constituents identified in pulp and paper mill effluents using the Salmonella/mammalian-microsome assay. Mutat Res, 79, 203–12.
  • Nestmann ER, Lee EGH. (1983). Mutagenicity of constituents of pulp and paper mill effluent in growing cells of Saccharomyces cerevisiae. Mutat Res, 119, 273–80.
  • New York State Department of Health (NYSDOH). (2005). Summary of Indoor and Outdoor Levels of Volatile Organic Compounds from Fuel Oil Heated Homes in NYS, 1997–2003. Retrieved February 2015, from https://www.health.ny.gov/environmental/indoors/air/fuel_oil.htm
  • Nicholson WJ, Selikoff IJ, Seidman H. (1978). Mortality experience of sytrene-polystyrene polymerization workers. Initial findings . Scand J Work Environ Health, 4, 247–52.
  • Nong A, Charest-Tardif G, Tardif R, Lewis DFV, Sweeney LM, Gargas ML, Krishnan K. (2007). Physiologically-based modeling of the inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice. J Toxicol Environ Health A, 70, 1838–48.
  • Norppa H, Vainio H. (1983). Induction of sister-chromatid exchanges by styrene analogues in cultured human lymphocytes. Mutat Res, 116, 379–87.
  • O’Brien PJ. (1991). Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact, 80, 1–41.
  • Organisation for Economic Cooperation and Development(OECD SIDS). (2002). Ethylbenzene (CAS No:100–41-4). UNEP Publications. [Online] Available at: http://www.inchem.org/documents/sids/sids/100414.pdf. Accessed 27 June 2014.
  • Organisation for Economic Cooperation and Development (OECD SIDS). (2009). OECD guideline for the testing of chemicals: carcinogenicity studies. 451, 7 September, 2009.
  • Organisation for Economic Cooperation and Development (OECD). (2011). OECD guideline for the testing of chemicals: extended One-Generation Reproductive Toxicity Study. 443, 28 July, 2011.
  • Pankow JF, Luo W, Tavakoli AD, Chen C, Isabelle LM. (2004). Delivery levels and behaviour of 1,3-butadiene, acrylonitrile, benzene, and other toxic volatile organic compounds in mainstream tobacco smoke from two brands of commercial cigarettes. Chem Res Toxicol, 17, 805–13.
  • Parkinson A, Leonard N, Draper A, Ogilvie BW. (2006). On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice. Drug Metab Rev, 38, 235–59.
  • Payne-Sturges DC, Burke TA, Breysse P, Diener-West M, Buckley TJ. (2004). Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community. Environ Health Perspect, 112, 589–98.
  • Pellizzari ED, Hartwell TD, Harris BS, Waddell RD, Whitaker DA, Erickson MD. (1982). Purgeable organic compounds in mother's milk. Bull Environ Contam Toxicol, 28, 322–28.
  • Phimister AJ, Williams KJ, Van Winkle LS, Plopper CG. (2005). Consequences of abrupt glutathione depletion in murine Clara cells: ultrastructural and biochemical investigations into the role of glutathione loss in naphthalene cytotoxicity. J Pharmacol Exp Ther, 314, 506–13.
  • Plopper CG, Van Winkle LS, Fanucchi MV, Malburg SRC, Nishio SJ, Chang A, Buckpitt AR. (2001). Early events in naphthalene-induced acute Clara cell toxicity. II. Comparison of glutathione depletion and histopathology by airway location.Am J Respir Cell Mol Biol, 24, 272–81.
  • Polzin GM, Kosa-Maines RE, Ashley DL, Watson CH. (2007). Analysis of volatile organic compounds in mainstream cigarette smoke. Environ Sci Technol, 41, 1297–302.
  • Prentice DE, Siegel RA, Donatsch P, Qureshi S, Ettlin RA. (1992). Mesulergine induced Leydig cell tumours, a syndrome involving the pituitary-testicular axis of the rat. Arch Toxicol, 15, 197–204.
  • Prentice DE, Meikle AW. (1995). A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man. Human Exper Toxicol, 14, 562–72.
  • Preston RJ, Williams GM. (2005). DNA-reactive carcinogens: mode of action and human cancer hazard. Crit Rev Toxicol, 35, 673–83.
  • Price RJ, Walters DG, Finch JM, Gabriel KL, Capen CC, Osimitz TG, Lake BG. (2007). A mode of action for induction of liver tumors by pyrethrins in the rat. Toxicol Appl Pharmacol, 218, 186–95.
  • Prosen CA, Moody DB, Stebbins WC, Smith DW, Sommers MS, Brown NJ, et al. (1990). Apical hair cells and hearing. Hear Res, 44, 179–93.
  • Pryor G, Rebert C, Kassay K, Kuiper H, Gordon R. (1991). The hearing loss associated with exposure to toluene is not caused by a metabolite. Brain Res Bull, 27, 109–13.
  • Rasoulpour RJ, Terry C, LeBaron MJ, Stebbins K. (2014). Mode-of-action and human relevance framework analysis for rat Leydig cell tumors associated with sulfoxaflor. Crit Rev Toxicol, 44, 25–44.
  • Rodgers IS, Baetcke KP. (1993). Interpretation of male rat renal tubule tumors. Environ Health Perspect, 101, 45–52.
  • Rodríguez-Puyol D. (1998). The aging kidney. Kidney Int, 54, 2247–65.
  • Römer KG, Federsel RJ, Freundt KJ. (1986). Rise of inhaled toluene, ethyl benzene, m-xylene, or mesitylene in rat blood after treatment with ethanol. Bull Environ Contam Toxicol, 37, 874–76.
  • Ross J, Plummer SM, Rode A, Scheer N, Bower CC, Vogel O. (2010). Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci, 116, 452–66.
  • Rossi L, Moore GA, Orrenius S, O’Brien PJ. (1986). Quinone toxicity in hepatocytes without oxidative stress. Arch Biochem Biophys, 251, 25–35.
  • Rowe BL, Toccalino PL, Moran MJ, Zogorski JS, Price CV. (2007). Occurrence and potential human-health relevance of volatile organic compounds in drinking water from domestic wells in the United States. Environ Health Perspect, 115, 1539.
  • Ruggenenti P, Schieppati A, Remuzzi G. (2001). Progression, remission, regression of chronic renal diseases. Lancet, 357, 1601–8.
  • Saghir SA, Rick DL. (2005). Ethylbenzene: in vitro metabolism in rat, mouse, and human liver and lung microsomes.Midland, Michigan: The Dow Chemical Company.
  • Saghir SA, Rick DL, Bartels MJ, Bus JS. (2006). In vitro metabolism of ethylbenzene by rat, mouse and human liver and lung microsomes. The Toxicologist, 90, 141.
  • Saghir SA, Rick DL, McClymont EL, Zhang F, Bus JS. (2007). Ethylbenzene: in vitro metabolism in rat, mouse, and human liver and lung microsomes. Phase II study. Midland, Michigan: The Dow Chemical Company.
  • Saghir SA, Rick DL, McClymont EL, Zhang F, Bartels MJ, Bus JS. (2009). Mechanism of ethylbenzene-induced mouse-specific lung tumor: metabolism of ethylbenzene by rat, mouse, and human liver and lung microsomes. Toxicol Sci, 107, 352–66.
  • Saghir SA, Zhang F, Rick DL, Kan L, Bus JS, Bartels MJ. (2010). In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis. Regul Toxicol Pharmacol, 57, 129–35.
  • Saiardi A, Bozzi Y, Baik JH, Borrelli E. (1997). Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron, 19, 115–26.
  • Saillenfait AM, Gallissot F, Morel G, Bonnet P. (2003). Developmental toxicities of ethylbenzene, ortho-, meta-, para-xylene and technical xylene in rats following inhalation exposure. Food Chem Toxicol, 41, 415–29.
  • Saillenfait AM, Gallissot F, Sabaté JP, Bourges-Abella N, Cadot R, Morel G, Lambert AM. (2006). Developmental toxicity of combined ethylbenzene and methylethylketone administered by inhalation to rats. Food Chem Toxicol, 44, 1287–98.
  • Sams C, Loizou GD, Cocker J, Lennard MS. (2004). Metabolism of ethylbenzene by human liver microsomes and recombinant human cytochrome P450s (CYP). Toxicol Lett, 147, 253–60.
  • Sanagi MM, Ling SL, Nasir Z, Ibrahim W, Abu Naim A. (2008). Determination of residual volatile organic compounds migrated from polystyrene food packaging into food simulant by headspace solid phase microextraction–gas chromatography. Malay J Anal Sci, 12, 542–51.
  • Sax SN, Bennett DH, Chillrud SN, Kinney PL, Spengler JD. (2004). Differences in source emission rates of volatile organic compounds in inner-city residences of New York City and Los Angeles. J Expo Anal Environ Epidemiol, 14, S95–109.
  • Sax SN, Bennett DH, Chillrud SN, Ross J, Kinney PL, Spengler JD. (2006). A cancer risk assessment of inner-city teenagers living in New York City and Los Angeles. Environ Health Perspect, 114, 1558–66.
  • Seidel SD, Schisler MR, Kleinert KM. (2006). Evaluation of Ethylbenzene in the Mouse Lymphoma (L5178YTK+/-) Forward Mutation Assay. Toxicology, & Environmental Research and Consulting, The Dow Chemical Company, Study ID 051157.
  • Sequeira DJ, Eyer CS, Cawley GF, Nick TG, Backes WL. (1992). Ethylbenzene-mediated induction of cytochrome P450 isozymes in male and female rats. Biochem Pharmacol, 44, 1171–82.
  • Sexton K, Adgate JL, Church TR, Ashley DL, Needham LL, Ramachandran G, et al. (2005). Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ Health Perspect, 113, 342–49.
  • Sexton K, Adgate JL, Ramachandran G, Pratt GC, Mongin SJ, Stock TH, Morandi MT. (2004). Comparison of personal, indoor, and outdoor exposures to hazardous air pollutants in three urban communities. Environ Sci Technol, 38, 423–30.
  • Sexton K, Mongin SJ, Adgate JL, Pratt GC, Ramachandran G, Stock TH, Morandi MT. (2007). Estimating volatile organic compound concentrations in selected microenvironments using time–activity and personal exposure data. J Toxicol Environ Health A, 70, 465–76.
  • Simon T, Kirman CR, Aylward LL, Budinsky RA, Rowlands JC, Long TF. (2008). Estimates of cancer potency of 2,3,4,7,8-pentachlorodibenzofuran using both nonlinear and linear approaches. Toxicol Sci, 106, 519–37.
  • Simpson BJB, Wu FCW, Sharpe RM. (1987). Isolation of human Leydig cells which are highly responsive to human chorionic gonadotropin. J Endocrinol Metab, 65, 415–22.
  • Slikker W Jr, Andersen ME, Bogdanffy MS, Bus JS, Cohen SD, Conolly RB, et al. (2004a). Dose-dependent transitions in mechanisms of toxicity. Toxicol Appl Pharmacol, 201, 203–25.
  • Slikker W Jr, Andersen ME, Bogdanffy MS, Bus JS, Cohen, SD, Conolly RB, et al. (2004b). Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol Appl Pharmacol, 201, 226–94.
  • Smyth HF Jr, Carpenter CP, Well CS, Pozzani UC, Striegel JA. (1962). Range-finding toxicity data: list VI. Am Ind Hyg Assoc J, 23, 95–107.
  • Spengler J, Lwebuga-Mukasa J, Vallarino J, Melly S, Chillrud S, Baker J, Minegishi T. (2011). Air Toxics Exposure from Vehicle Emissions at a U.S. Border Crossing: Buffalo Peace Bridge Study. Research Report #158. Health Effects Institute, Boston, MA. [Online] Available at: http://pubs.healtheffects.org/view.php?id = 362. Accessed on 27 June 2014.
  • Stott WT, Johnson KA, Bahnemann R, Day SJ, McGuirk RL. (2003). Evaluation of potential modes of action of inhaled ethylbenzene in rats and mice. Toxicol Sci, 71, 53–66.
  • Stump DG. (2004a). An inhalation two-generation reproductive toxicity study of ethylbenzene in rats including developmental neurotoxicity assessment of the F2 generation. Study Number, – WIL-186030, WIL Research Laboratories, Inc., Ashland, OH. Sponsored by the Ethylbenzene Panel, American Chemistry Council, Arlington, Virginia.
  • Stump DG. (2004b). A 28-day inhalation splenic antibody formation study of ethylbenzene in rats. Arlington, Virginia: American Chemistry Council.
  • Styrene Forum. (2012). http://www.styreneforum.org/index.html. Page last modified 26 March 2012, accessed October 2013.
  • Styrene Information and Research Center (SIRC) (2011). http://youknowstyrene.org/#&panel1–3. Page copyrighted 2011, accessed September 2014.
  • Su FC, Jia C, Batterman S. (2012). Extreme value analyses of VOC exposures and risks: a comparison of RIOPA and NHANES datasets. Atmos Environ, 62, 97–106.
  • Su FC, Mukherjee B, Batterman S. (2013). Determinants of personal, indoor and outdoor VOC concentrations: an analysis of the RIOPA data. Environ Res, 126, 192–203.
  • Surveillance Epidemiology and End Results (SEER). (2014). Cancer Stat Fact Sheets for Liver,Lung, and Testis Cancer. [Online] April 15, 2014 release, available at: http://seer.cancer.gov/ Accessed on March 3, 2015.
  • Susten AS, Niemeier RW, Simon SD. (1990). In vivo percutaneous absorption studies of volatile organic solvents in hairless mice II. Toluene, ethylbenzene and aniline.J Appl Toxicol, 10, 217–25.
  • Symanski E, Stock TH, Tee PG, Chan W. (2009). Demographic, residential, and behavioral determinants of elevated exposures to benzene, toluene, ethylbenzene, and xylenes among the U.S. population: results from 1999–2000 NHANES. J Toxicol Environ Health A, 72, 915–24.
  • Tang W, Hemm I, Eisenbrand G. (2000). Estimation of human exposure to styrene and ethylbenzene. Toxicology, 144, 39–50.
  • Tapper MA, Sheedy BR, Hammermeister DE, Schmieder PK. (2000). Depletion of cellular protein thiols as an indicator of arylation in isolated trout hepatocytes exposed to 1,4-benzoquinone. Toxicol Sci, 55, 327–34.
  • Tardif R, Charest-Tardif G, Brodeur J. (1996). Comparison of the influence of binary mixtures versus a ternary mixture of inhaled aromatic hydrocarbons on their blood kinetics in the rat. Arch Toxicol, 70, 405–13.
  • Tardif R, Charest-Tardif G, Brodeur J, Krishnan K. (1997). Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol Appl Pharmacol, 144, 120–34.
  • Toxicology Excellence for Risk Assessment (TERA). (2007). Report of the Peer Consultation Meeting on Ethylbenzene. [Online] Available at: http://www.tera.org/peer/VCCEP/Ethylbenzene/VCCEP%20ETHYLBENZENE%20MEETING%20REPORT%20final.pdf. Accessed on 8 July 2014.
  • Travlos GS, Hard GC, Betz LJ, Kissling GE. (2011). Chronic progressive nephropathy in male F344 rats in 90-day toxicity studies: its occurrence and association with renal tubule tumors in subsequent 2-year bioassays. Toxicol Pathol, 39, 381–9.
  • Triebig G, Claus D, Csuzda I, Druschky KF, Holler P, Kinzel W, et al. (1988). Cross-sectional epidemiological study on neurotoxicity of solvents in paints and lacquers. Int Arch Occup Environ Health, 60, 233–41.
  • US Environmental Protection Agency (US EPA). (1980). Acquisition and Chemical Analysis of Mother's Milk for Selected Toxic Substances. EPA-560/13–80-029. Office of Pesticides and Toxic Substances. Washington, D.C.
  • US Environmental Protection Agency (US EPA). (1991). Integrated Risk Information System (IRIS). Ethylbenzene. (CASRN 100–41-4). [Online] Available at: http://www.epa.gov/iris/subst/0051.htm. Accessed on 8 July 2014.
  • US Environmental Protection Agency (US EPA). (1994). Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8–90/066F.
  • US Environmental Protection Agency (US EPA). (2000a). Voluntary Children's Chemical Evaluation Program. Federal Register: 65(248). [Online] Available at: http://www.epa.gov/fedrgstr/EPAFR-CONTENTS/2000/December/Day-26/contents.htm. Accessed on 9 July 2014
  • US Environmental Protection Agency (US EPA). (2000b). Methodology for Selecting Chemicals for the Voluntary Children's Chemical Evaluation Program (VCCEP) Pilot. Office of Pollution Prevention and Toxics. December 5, 2000. Available at http://www.epa.gov/oppt/vccep/pubs/vccepmth.pdf. Accessed on July 11, 2014
  • US Environmental Protection Agency (US EPA). (2005a). Guidance on Selecting Age Groups for Monitoring and Assessing Childhood Exposures to Environmental Contaminants. EPA/630/P-03/033F. Risk Assessment Forum, Washington, D.C. [Online] Available at: http://nepis.epa.gov/Exe/ZyPURL.cgi?Dockey = 9100BHYH.TXT. Accessed 1 July 2014.
  • US Environmental Protection Agency (US EPA). (2005b). Guidelines for carcinogen risk assessment. [Online] Available at: http://www.epa.gov/cancerguidelines/. Accessed on 9 July 2014
  • US Environmental Protection Agency (US EPA). (2009). Risk Assessment Guidance for Superfund Volume I: human Health Evaluation Manual (Part F, Supplemental Guidance for Inhalation Risk Assessment). Final. EPA,-540-R-070–002.
  • US Environmental Protection Agency (US EPA). (2010). The Analysis of Regulated Contaminant Occurrence Data from Public Water Systems in Support of the Second Six-Year Review of National Primary Drinking Water Regulations. EPA-815-B-09–006.
  • US Environmental Protection Agency (US EPA). (2011a). Background Indoor Air Concentrations of Volatile Organic Compounds in North American Residences (1990–2005): a Compilation of Statistics for Assessing Vapor Intrusion. EPA 530-R-10–001. [Online] Available at: http://www.epa.gov/oswer/vaporintrusion/documents/oswer-vapor-intrusion-background-Report-062411.pdf/Accessed 1 July 2014.
  • US Environmental Protection Agency (US EPA). (2011b). Exposure Factors Handbook: 2011 Edition. EPA/600-R-090/052F. Office of Research and Development, Washington, D.C. [Online] Available at: http://www.epa.gov/ncea/efh/pdfs/efh-complete.pdf. Accessed 1 July 2014.
  • US Environmental Protection Agency (US EPA). (2013a). 2008 National Emissions Inventory: review, Analysis and Highlights. EPA-454/R-13–005. Available at: http://www.epa.gov/ttn/chief/net/2008report.pdf.
  • US Environmental Protection Agency (US EPA). (2013b). 2011 National Emissions Inventory: review, Analysis and Highlights. EPA-454/R-13–005. Office of Air Quality Planning and Standards, Research Triangle Park, NC. Retrieved February 2015, from http://www.epa.gov/ttn/chief/net/2011inventory.html.
  • US Environmental Protection Agency (US EPA). (2013c). Methanol (CASRN 67–56-1). Integrated Risk Information System. [Online] Avalable at http://www.epa.gov/iris/subst/0305.htm. Accessed 17 December 2014.
  • US Environmental Protection Agency (US EPA). (2014a). 2012 National Monitoring Programs Annual Report (UATMP, NATTS, CSATAM). (EPA-454/R-14–006a). Research Triangle Park, NC: Retrieved from http://www.epa.gov/ttnamti1/uatm.html.
  • US Environmental Protection Agency (US EPA). (2014b). Release Chemical Report. Reports generated at http://iaspub.epa.gov/triexplorer/tri_release.chemical. Accessed December 2014.
  • US Environmental Protection Agency (US EPA). (2014c). 2012 Toxics Release Inventory National Analysis Overview. (http://www2.epa.gov/toxics-release-inventory-tri-program/2012-tri-national-analysis-overview).
  • US Environmental Protection Agency (US EPA). (2015). 2013 Toxics Release Inventory National Analysis. Retrieved February 2015, from http://www2.epa.gov/toxics-release-inventory-tri-program/2013-toxics-release-inventory-national-analysis.
  • US Food and Drug Administration (FDA). (2002). Guidance for Industry: preparation of Premarket Submissions for Food Contact Substances: chemistry Recommendations. [Online] Available at: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm081818.htm. Accessed on 9 July 2014.
  • US Food and Drug Administration (FDA). (2004a). TDS Food List and Consumption Amounts. [Online] Available at: http://www.fda.gov/Food/FoodScienceResearch/TotalDietStudy/ucm184232.htm. Accessed on 30 June 2014.
  • US Food and Drug Administration (FDA). (2004b). Total Diet Study. [Online] Available at: http://www.fda.gov/Food/FoodScienceResearch/TotalDietStudy/default.htm. Accessed on 30 June 2014.
  • Vassallo JD, Hicks SM, Born SL, Daston GP. (2004). Roles for epoxidation and detoxification of coumarin in determining species differences in Clara cell toxicity. Toxicol Sci, 82, 26–33. Erratum in: Toxicol Sci (2004) 82(2).
  • Wallace LA, Pellizzari ED, Hartwell TD, Sparacino CM, Sheldon LS, Zelon H. (1985). Personal exposures, indoor-outdoor relationships, and breath levels of toxic air pollutants measured for 355 persons in New Jersey. Atmos Environ, 19, 1651–61.
  • Wallace LA, Pellizzari ED. (1986a). Personal air exposures and breath concentrations of benzene and other volatile hydrocarbons for smokers and nonsmokers. Toxicol Lett, 35, 113–16.
  • Wallace LA, Pellizzari ED, Hartwell TD, Whitmore R, Sparacino C, Zelon H. (1986b). Total exposure assessment methodology (TEAM) study: personal exposures, indoor-outdoor relationships, and breath levels of volatile organic compounds in New Jersey. Environ Int, 12, 369–87.
  • Wallace L, Pellizzari E, Hartwell TD, Perritt R, Zeigenfus R. (1987a). Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health, 42, 272–79.
  • Wallace LA, Pellizzari ED, Hartwell TD, Sparacino C, Whitmore R, Sheldon L, Zelon H, Perritt R. (1987b). The TEAM (Total Exposure Assessment Methodology) Study: personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ Res, 43, 290–307.
  • Wallace LA, Pellizzari ED, Hartwell TD, Whitmore R, Zelon H, Perritt R, Sheldon L. (1988). The California TEAM study: breath concentrations and personal exposures to 26 volatile compounds in air and drinking water of 188 residents of Los Angeles, Antioch, and Pittsburg, CA. Atmos Environ, 22, 2141–63.
  • Wallace LA, Pellizzari ED, Hartwell TD, Davis V, Michael LC, Whitmore RW. (1989). The influence of personal activities on exposure to volatile organic compounds. Environ Res, 50, 37–55.
  • Wallace L, Pellizzari E, Wendel C. (1991). Total volatile organic concentrations in 2700 personal, indoor; and outdoor air samples collected in the US EPA TEAM studies. Indoor Air, 1, 465–77.
  • Wallace LA. (1991a). Comparison of risks from outdoor and indoor exposure to toxic chemicals. Environ Health Perspect, 95, 7–13.
  • Wallace LA. (1991b). Personal exposure to 25 volatile organic compounds. EPA's, 1987 TEAM study in Los Angeles, California. Toxicol Ind Health, 7, 203–8.
  • Wang SW, Majeed MA, Chu PL, Lin HC. (2009). Characterizing relationships between personal exposures to VOCs and socioeconomic, demographic, behavioral variables. Atmos Environ, 43, 2296–302.
  • Weisel CP, Zhang J, Turpin BJ, Morandi MT, Colome S, Stock TH, et al. (2005). Relationships of Indoor, Outdoor, and Personal Air (RIOPA). Part I. Collection methods and descriptive analyses.Res Rep Health Eff Inst, 130, 1–107.
  • Wheeler AJ, Wong SL, Khoury C, Zhu J. (2013). Predictors of indoor BTEX concentrations in Canadian residences. Health Rep, 2, 11–7.
  • Whysner J, Ross PM, Williams GM. (1996). Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther, 71, 153–91.
  • Wittrig B. (2002). Monitoring volatiles in food contact packaging. Excerpted from Food Quality Nov/Dec 2002 issue.
  • Wolf DC, Mann PC. (2005). Confounders in interpreting pathology for safety and risk assessment. Toxicol Appl Pharmacol, 202, 302–8.
  • Wolf MA, Rowe VK, McCollister DD, Hollingsworth RL, Oyen F. (1956). Toxicological studies of certain alkylated benzenes and benzene; experiments on laboratory animals. AMA Arch Ind Health, 14, 387–98.
  • Wollny HE. (2000). Cell mutation assay at the thymidine kinase locus (TK+/−) in mouse lymphoma L5178Y cells (soft agar method) with ethylbenzene. RCC-CCR Project No, 635300. RCC-Cytotest Cell Research GmbH, Germany. Brussels, Belgium: Sponsored by the Styrenics Steering Committee, CEFIC.
  • Xie J, Wang X, Sheng G, Bi X, Fu J. (2003). Determination of tobacco smoking influence on volatile organic compounds constituent by indoor tobacco smoking simulation experiment. Atmos Environ, 37, 3365–74.
  • Yant WP, Schrenk HH, Waite CP, Patty FA. (1930). Acute response of guinea pigs to vapors of some new commercial organic compounds. II. Ethyl benzene.Pub Health Rep, 45, 1241–50.
  • Yuan W, Sequeira DJ, Cawley GF, Eyer CS, Backes WL. (1997a). Time course for the modulation of hepatic cytochrome P450 after administration of ethylbenzene and its correlation with toluene metabolism. Arch Biochem Biophys, 339, 55–63.
  • Yuan W, Serron SC, Haddican MM, Cawley GF, Eyer CS, Backes WL. (1997b). Ethylbenzene modulates the expression of different cytochrome P-450 isozymes by discrete multistep processes. Biochim Biophys Acta, 1334, 361–72.
  • Zhang M, Wang Y, Wang Q, Yang D, Zhang J, Wang F, Gu Q. (2013). Ethylbenzene-induced hearing loss, neurobehavioral function, and neurotransmitter alterations in petrochemical workers. J Occup Environ Med, 55, 1001–6.
  • Zhang ZN, Guo B, Zhang JS, DeStefano PJ, Crawford JA, Hunt A, Abraham JL. (2003). Determination of volatile organic compounds in residential buildings. International Conference on Indoor Air Quality Problems and Engineering Solutions, July 21–23, 2003.
  • Zhu J, Newhook R, Marro L, Chan CC. (2005). Selected volatile organic compounds in residential air in the city of Ottawa, Canada. Environ Sci Technol, 39, 3964–71.
  • Zhu J, Wong SL, Cakmak S. (2013). Nationally representative levels of selected volatile organic compounds in Canadian residential indoor air: population-based survey. Environ Sci Technol, 47, 13276–83.
  • Zipf WB, Payne AH, Kelch RP. (1978). Prolactin, growth hormone and luteinizing hormone in the maintenance of testicular luteinizing hormone receptors. Endocrinology, 103, 595–600.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.